Human Molecular Genetics, 2002, Vol. 11, No. 17 1967-1976
© 2002 Oxford University Press
Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor
1Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA and 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Received March 12, 2002; Accepted May 22, 2002
Kennedy's disease is a degenerative disease of motor neurons in which the causative mutation is expansion of a CAG/polyglutamine tract near the 5' end of the androgen receptor gene. The mutant protein misfolds, aggregates, and interacts abnormally with other proteins, leading to a novel, toxic gain of function and an alteration of normal function. We used a cell culture model to explore the mechanisms underlying the alterations in androgen receptor function conferred by the mutation. Here we show that cells expressing the wild-type androgen receptor with 24 CAG repeats respond to ligand by showing trophic effects including prolonged survival in low serum, whereas cells expressing the mutant receptor with 65 CAG repeats do not show a robust trophic response. This partial loss of function correlates with decreased levels of the mutant protein due to its preferential degradation by the ubiquitin–proteasome pathway. Expression analysis using oligonucleotide arrays confirms that the mutant receptor has undergone a partial loss of function, and fails to regulate a subset of genes whose expression is normally affected by ligand activation of the wild-type receptor. The mutant receptor has also undergone several functionally important post-translational modifications in the absence of ligand that the wild-type receptor undergoes in the presence of ligand, including acetylation and phosphorylation. These modifications correlate with a ligand-independent gain of function exhibited by the mutant receptor in expression analysis. Our findings suggest that polyglutamine expansion alters androgen receptor function by promoting its degradation and by modifying its activity as a transcription factor.
* To whom correspondence should be addressed at: Department of Pathology, University of Michigan School of Medicine, 1301 Catherine, 4233 Medical Science 1, Ann Arbor, MI 48109-0602, USA. Tel.: +1 7349361887; Fax: +1 7347636476; Email: liebermn{at}umich.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Palazzolo, B. G. Burnett, J. E. Young, P. L. Brenne, A. R. La Spada, K. H. Fischbeck, B. W. Howell, and M. Pennuto Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity Hum. Mol. Genet., July 1, 2007; 16(13): 1593 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model J. Neurosci., May 9, 2007; 27(19): 5115 - 5126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Thomas Jr, G. S. Fraley, V. Damien, L. B. Woodke, F. Zapata, B. L. Sopher, S. R. Plymate, and A. R. La Spada Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy Hum. Mol. Genet., July 15, 2006; 15(14): 2225 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hodges, A. D. Strand, A. K. Aragaki, A. Kuhn, T. Sengstag, G. Hughes, L. A. Elliston, C. Hartog, D. R. Goldstein, D. Thu, et al. Regional and cellular gene expression changes in human Huntington's disease brain Hum. Mol. Genet., March 15, 2006; 15(6): 965 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, N. Dadgar, M. Albertelli, A. Scheller, R. L. Albin, D. M. Robins, and A. P. Lieberman Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant Protein Am. J. Pathol., January 1, 2006; 168(1): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fu, Y.-s. Gao, A. Tousson, A. Shah, T.-L. L. Chen, B. M. Vertel, and E. Sztul Nuclear Aggresomes Form by Fusion of PML-associated Aggregates Mol. Biol. Cell, October 1, 2005; 16(10): 4905 - 4917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thomas, Z. Yu, N. Dadgar, S. Varambally, J. Yu, A. M. Chinnaiyan, and A. P. Lieberman The Unfolded Protein Response Modulates Toxicity of the Expanded Glutamine Androgen Receptor J. Biol. Chem., June 3, 2005; 280(22): 21264 - 21271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Adachi, M. Katsuno, M. Minamiyama, M. Waza, C. Sang, Y. Nakagomi, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients Brain, March 1, 2005; 128(3): 659 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Thomas, N. Dadgar, A. Aphale, J. M. Harrell, R. Kunkel, W. B. Pratt, and A. P. Lieberman Androgen Receptor Acetylation Site Mutations Cause Trafficking Defects, Misfolding, and Aggregation Similar to Expanded Glutamine Tracts J. Biol. Chem., February 27, 2004; 279(9): 8389 - 8395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Taylor, F. Tanaka, J. Robitschek, C. M. Sandoval, A. Taye, S. Markovic-Plese, and K. H. Fischbeck Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein Hum. Mol. Genet., April 1, 2003; 12(7): 749 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Luthi-Carter, A. D. Strand, S. A. Hanson, C. Kooperberg, G. Schilling, A. R. La Spada, D. E. Merry, A. B. Young, C. A. Ross, D. R. Borchelt, et al. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects Hum. Mol. Genet., August 15, 2002; 11(17): 1927 - 1937. [Abstract] [Full Text] [PDF]
|
|